| 摘要 |
<p>An inhalation medicament comprising orazipone and a beta2-adrenoreceptor agonist and/or a corticosteroid as a combined preparation is provided. Optionally the medicament also comprises one or more pharmaceutically acceptable additive, diluents or carriers. The beta-2adrenoreceptor agonist the corticosteroid may comprise formoterol and budesonide.</p> |
